Deal Snapshot
Zura Bio Enters Business Combination with JATT acquisition to Trade as NASDAQ: ZURA
Monday 27 March 2023

California-based clinical-stage biotechnology company Zura Bio Ltd has closed its business combination with US-based special purpose acquisition Company JATT acquisition Corp, (NYSE: JATT), the company said.

Business combination results in approximately USD 65m in gross cash proceeds to support research and development initiatives and potential future acquisitions.

Date Published: 27/03/2023